Renin-Angiotensin-Aldosterone Inhibitors and Susceptibility to and Severity of COVID-19
- PMID: 32558905
- DOI: 10.1001/jama.2020.11401
Renin-Angiotensin-Aldosterone Inhibitors and Susceptibility to and Severity of COVID-19
Comment on
-
Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality.JAMA. 2020 Jul 14;324(2):168-177. doi: 10.1001/jama.2020.11301. JAMA. 2020. PMID: 32558877 Free PMC article.
Similar articles
-
Heartbeat: interaction of renin-angiotensin-aldosterone blocking drugs with COVID-19 disease susceptibility and severity.Heart. 2020 Oct;106(19):1451-1453. doi: 10.1136/heartjnl-2020-318164. Heart. 2020. PMID: 32928982 No abstract available.
-
[Role of age, comorbidity and renin- angiotensin-aldosterone system in COVID-19. Effects of ACE inhibitors and angiotensin receptor blockers].Kardiologiia. 2020 Apr 8;60(4):4-9. doi: 10.18087/cardio.2020.4.n1122. Kardiologiia. 2020. PMID: 32394850 Russian.
-
A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19.Am J Cardiol. 2020 Sep 1;130:159-161. doi: 10.1016/j.amjcard.2020.05.038. Epub 2020 Jun 2. Am J Cardiol. 2020. PMID: 32624189 Free PMC article. No abstract available.
-
What solid organ transplant healthcare providers should know about renin-angiotensin-aldosterone system inhibitors and COVID-19.Clin Transplant. 2020 Jul;34(7):e13991. doi: 10.1111/ctr.13991. Epub 2020 Jun 15. Clin Transplant. 2020. PMID: 32446267 Free PMC article. Review.
-
Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2.J Cardiovasc Pharmacol. 2020 Jun;75(6):526-529. doi: 10.1097/FJC.0000000000000840. J Cardiovasc Pharmacol. 2020. PMID: 32301766 Free PMC article. Review.
Cited by
-
Pharmacological disruption of mSWI/SNF complex activity restricts SARS-CoV-2 infection.Nat Genet. 2023 Mar;55(3):471-483. doi: 10.1038/s41588-023-01307-z. Epub 2023 Mar 9. Nat Genet. 2023. PMID: 36894709 Free PMC article.
-
Computational and in vitro experimental analyses of the anti-COVID-19 potential of Mortaparib and MortaparibPlus.Biosci Rep. 2021 Oct 29;41(10):BSR20212156. doi: 10.1042/BSR20212156. Biosci Rep. 2021. PMID: 34647577 Free PMC article.
-
Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm.Cardiovasc Drugs Ther. 2021 Apr;35(2):231-247. doi: 10.1007/s10557-020-07120-8. Epub 2021 Jan 6. Cardiovasc Drugs Ther. 2021. PMID: 33404925 Free PMC article. Review.
-
Hypertension, medications, and risk of severe COVID-19: A Massachusetts community-based observational study.J Clin Hypertens (Greenwich). 2021 Jan;23(1):21-27. doi: 10.1111/jch.14101. Epub 2020 Nov 21. J Clin Hypertens (Greenwich). 2021. PMID: 33220171 Free PMC article.
-
The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection.J Cannabis Res. 2020;2(1):23. doi: 10.1186/s42238-020-00030-4. Epub 2020 Jul 31. J Cannabis Res. 2020. PMID: 32835160 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
